In pancreatic cancer, TAM-M2 cells have been found to enhance aerobic glycolysis in pancreatic cancer cells, thereby promoting tumor invasion and metastasis via the secretion of the chemokine CCL18, which interacts with its receptor, PITPNM3 [186]. Here, CCL18 is linked to familial pancreatic carcinoma.